Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Flixotide® (fluticasone) 50 micrograms/dose Evohaler
Tier 2 – medium impact
Date of issue: 8th February 2024
Flixotide® (fluticasone) 50 micrograms/dose Evohaler is out of stock until early March 2024.
Flixotide® (fluticasone) 50 micrograms/dose Accuhaler remains available and can support a full uplift in demand.
Flixotide® (fluticasone) 125 micrograms/dose Evohaler and 100 micrograms/dose Accuhaler remain available and can support a full uplift in demand.
Where these are not suitable options, alternative corticosteroid inhalers, including beclomethasone 100 micrograms inhalers, are available.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Flixotide® (fluticasone) 50 micrograms/dose Evohaler appeared first on Community Pharmacy England.